SuperworthAdicet Bio shares outstanding ACET
Diluted shares outstanding, averaged over each quarter, from 2017.
- Latest quarter, to Jun 30, 2026
- 10.7M
- On a year earlier
- +88.8%
- more shares
Adicet Bio had 10.7M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 88.8% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 10.4M | +83% |
| FY2024 | 5.7M | +110% |
| FY2023 | 2.7M | +1% |
| FY2022 | 2.7M | +26% |
| FY2021 | 2.1M | +73% |
| FY2020 | 1.2M | +350% |
| FY2019 | 272.4K | +9% |
| FY2018 | 250.5K | +521% |
| FY2017 | 40.3K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 10.7M | +89% | |
| Q1 FY26 | 10.7M | +89% | |
| Q4 FY25 | 10.4M | +83% | |
| Q3 FY25 | 5.7M | +0% | |
| Q2 FY25 | 5.7M | +0% | |
| Q1 FY25 | 5.7M | +15% | |
| Q4 FY24 | 5.7M | +110% | |
| Q3 FY24 | 5.7M | +111% | |
| Q2 FY24 | 5.7M | +111% | |
| Q1 FY24 | 4.9M | +84% | |
| Q4 FY23 | 2.7M | +1% | |
| Q3 FY23 | 2.7M | +3% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Adicet Bio
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.